Recent Advances in Biocatalysis for Drug Synthesis

Biocatalysis is constantly providing novel options for the synthesis of active pharmaceutical ingredients (APIs). In addition to drug development and manufacturing, biocatalysis also plays a role in drug discovery and can support many active ingredient syntheses at an early stage to build up entire...

Full description

Bibliographic Details
Main Authors: Alina Kinner, Philipp Nerke, Regine Siedentop, Till Steinmetz, Thomas Classen, Katrin Rosenthal, Markus Nett, Jörg Pietruszka, Stephan Lütz
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/10/5/964
_version_ 1797501465733890048
author Alina Kinner
Philipp Nerke
Regine Siedentop
Till Steinmetz
Thomas Classen
Katrin Rosenthal
Markus Nett
Jörg Pietruszka
Stephan Lütz
author_facet Alina Kinner
Philipp Nerke
Regine Siedentop
Till Steinmetz
Thomas Classen
Katrin Rosenthal
Markus Nett
Jörg Pietruszka
Stephan Lütz
author_sort Alina Kinner
collection DOAJ
description Biocatalysis is constantly providing novel options for the synthesis of active pharmaceutical ingredients (APIs). In addition to drug development and manufacturing, biocatalysis also plays a role in drug discovery and can support many active ingredient syntheses at an early stage to build up entire scaffolds in a targeted and preparative manner. Recent progress in recruiting new enzymes by genome mining and screening or adapting their substrate, as well as product scope, by protein engineering has made biocatalysts a competitive tool applied in academic and industrial spheres. This is especially true for the advances in the field of nonribosomal peptide synthesis and enzyme cascades that are expanding the capabilities for the discovery and synthesis of new bioactive compounds via biotransformation. Here we highlight some of the most recent developments to add to the portfolio of biocatalysis with special relevance for the synthesis and late-stage functionalization of APIs, in order to bypass pure chemical processes.
first_indexed 2024-03-10T03:18:48Z
format Article
id doaj.art-ced19109aa7f4727916473fcec86ad77
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T03:18:48Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-ced19109aa7f4727916473fcec86ad772023-11-23T10:09:07ZengMDPI AGBiomedicines2227-90592022-04-0110596410.3390/biomedicines10050964Recent Advances in Biocatalysis for Drug SynthesisAlina Kinner0Philipp Nerke1Regine Siedentop2Till Steinmetz3Thomas Classen4Katrin Rosenthal5Markus Nett6Jörg Pietruszka7Stephan Lütz8Chair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyChair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyChair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyLaboratory for Technical Biology, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyInstitute of Bio- and Geosciences: Biotechnology (IBG-1), Forschungszentrum Jülich, 52428 Jülich, GermanyChair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyLaboratory for Technical Biology, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyInstitute of Bio- and Geosciences: Biotechnology (IBG-1), Forschungszentrum Jülich, 52428 Jülich, GermanyChair for Bioprocess Engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, 44227 Dortmund, GermanyBiocatalysis is constantly providing novel options for the synthesis of active pharmaceutical ingredients (APIs). In addition to drug development and manufacturing, biocatalysis also plays a role in drug discovery and can support many active ingredient syntheses at an early stage to build up entire scaffolds in a targeted and preparative manner. Recent progress in recruiting new enzymes by genome mining and screening or adapting their substrate, as well as product scope, by protein engineering has made biocatalysts a competitive tool applied in academic and industrial spheres. This is especially true for the advances in the field of nonribosomal peptide synthesis and enzyme cascades that are expanding the capabilities for the discovery and synthesis of new bioactive compounds via biotransformation. Here we highlight some of the most recent developments to add to the portfolio of biocatalysis with special relevance for the synthesis and late-stage functionalization of APIs, in order to bypass pure chemical processes.https://www.mdpi.com/2227-9059/10/5/964biotransformationactive pharmaceutical ingredient (API)drug discoverynonribosomal peptide synthesisprotein engineeringscaffold forming
spellingShingle Alina Kinner
Philipp Nerke
Regine Siedentop
Till Steinmetz
Thomas Classen
Katrin Rosenthal
Markus Nett
Jörg Pietruszka
Stephan Lütz
Recent Advances in Biocatalysis for Drug Synthesis
Biomedicines
biotransformation
active pharmaceutical ingredient (API)
drug discovery
nonribosomal peptide synthesis
protein engineering
scaffold forming
title Recent Advances in Biocatalysis for Drug Synthesis
title_full Recent Advances in Biocatalysis for Drug Synthesis
title_fullStr Recent Advances in Biocatalysis for Drug Synthesis
title_full_unstemmed Recent Advances in Biocatalysis for Drug Synthesis
title_short Recent Advances in Biocatalysis for Drug Synthesis
title_sort recent advances in biocatalysis for drug synthesis
topic biotransformation
active pharmaceutical ingredient (API)
drug discovery
nonribosomal peptide synthesis
protein engineering
scaffold forming
url https://www.mdpi.com/2227-9059/10/5/964
work_keys_str_mv AT alinakinner recentadvancesinbiocatalysisfordrugsynthesis
AT philippnerke recentadvancesinbiocatalysisfordrugsynthesis
AT reginesiedentop recentadvancesinbiocatalysisfordrugsynthesis
AT tillsteinmetz recentadvancesinbiocatalysisfordrugsynthesis
AT thomasclassen recentadvancesinbiocatalysisfordrugsynthesis
AT katrinrosenthal recentadvancesinbiocatalysisfordrugsynthesis
AT markusnett recentadvancesinbiocatalysisfordrugsynthesis
AT jorgpietruszka recentadvancesinbiocatalysisfordrugsynthesis
AT stephanlutz recentadvancesinbiocatalysisfordrugsynthesis